David Lomas
Deputy Chair of the Science Advisory Committee at Genomics England Limited. David is also Professor at UCL
Working in the 'GenOMICC study on COVID-19 patients' project.
As a member of Genomics England Limited is working in partnership with the GenOMICC consortium and with the NHS to deliver whole genome sequencing of up to 20,000 people who have been severely affected by COVID-19 - requiring intensive care - and 15,000 people who had mild symptoms .
This study aims to find out whether there are genetic factors that mean that some people experience severe symptoms whilst others experience only mild symptoms.
https://www.genomicsengland.co.uk/covid-19/
https://www.genomicsengland.co.uk/about-genomics-england/the-board/science-advisory-committee/"
Working in the 'GenOMICC study on COVID-19 patients' project.
As a member of Genomics England Limited is working in partnership with the GenOMICC consortium and with the NHS to deliver whole genome sequencing of up to 20,000 people who have been severely affected by COVID-19 - requiring intensive care - and 15,000 people who had mild symptoms .
This study aims to find out whether there are genetic factors that mean that some people experience severe symptoms whilst others experience only mild symptoms.
https://www.genomicsengland.co.uk/covid-19/
https://www.genomicsengland.co.uk/about-genomics-england/the-board/science-advisory-committee/"
Country:
UK